Energy ETFs Riding Oil’s Surge to Gains in 2026
Oil’s surge fuels a wave of gains in key energy ETFs, led by XLE, OIH, and PBT, as supply, demand, and drilling budge...
When To Choose Price Weighted Index
This intro covers scenarios where a price-weighted index may be appropriate and how it contrasts with alternative indexing methods.
22,667 articles
AXT'S Sold Shares Worth: Should Investors Buy or Sell Now
Insider activity often sparks debate among investors. This article breaks down AXT's sold shares worth $1.41 million ...
Prem Watsa Adds Million: Is UA Turnaround Worth It Now?
When a veteran value investor piles into a beaten-down name, traders take notice. Prem Watsa recently added to his Un...
Dutch Bros Doubled Over: Can It Triple by 2030 and Beyond?
Dutch Bros has shown rapid growth in recent years. This investing guide breaks down how the company wins customers, w...
What Know About This Palvella Insider Sale After 476K Rally
Palvella Therapeutics just saw a notable insider move after a multi-hundred percent rally. This guide breaks down the...
NuScale Power Stock Powering: What Investors Should Know
NuScale Power stock has been under pressure as investors digest macro concerns and regulatory headwinds. This guide b...
Where Will QuantumScape (QS) Stock Be in 3 Years Ahead?
QuantumScape's solid-state battery efforts could redefine EV charging. This guide digs into what might drive QS stock...
Amazon Actually Once-In-A-Decade Bargain: Is It Time to Buy?
Investors are weighing Amazon's retail muscle against cloud and AI competition. This guide asks: could amazon actuall...
Calling NuScale Power Before November: A Buy Thesis for 2024
NuScale Power trades on potential milestones and financing clarity. This guide explains why investors may consider ca...
Amazon Latest Giant Sign with Under-The-Radar Semiconductors
A leading cloud giant reportedly inks a multi-year deal with a niche semiconductor maker. This article breaks down wh...
What Does Nayax President's Sale Mean for Investors?
A recent Insider Form 4 reveals Nayax Ltd.'s President sold 4,500 shares after exercising options. Here’s how to read...
AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status